Asia-Pacific Respiratory Devices Market Report 2020-2025: Market Breakdown by Diagnostic and Monitoring Devices, Therapeutic Devices & Disposables
14 oct. 2020 04h14 HE
|
Research and Markets
Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Asia-Pacific Respiratory Devices Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. ...
Global Pneumatic Nebulizers Market Analysis & Forecasts, 2012-2019 & 2020-2027
01 oct. 2020 07h24 HE
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Pneumatic Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Pneumatic...
Global Nebulizers Market Trajectory & Analytics, 2012-2019 & 2020-2027
01 oct. 2020 06h44 HE
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Nebulizers Market to Reach...
Nebulizer Market Worth USD 1,778.8 Million at 8.1% CAGR; Large Medical Device Manufacturers Such as Philips and Omron to Develop Products to Deal with the COVID-19 Outbreak: Fortune Business Insights™
14 sept. 2020 07h55 HE
|
Fortune Business Insights
Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence...
InCarda Therapeutics Appoints Daniel G. Welch as Executive Chairman of Board of Directors
03 avr. 2019 08h00 HE
|
InCarda Therapeutics, Inc.
SAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for...
New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies
07 févr. 2019 08h05 HE
|
InCarda Therapeutics, Inc.
U.S. Patent Broadly Expands Coverage for Inhaled Treatment of Cardiovascular Disease to Include all Class I – IV Antiarrhythmic Drugs Additional U.S. Patent Provides Coverage for Combination of...
New 2-in-1 powder aerosol medicine to stop deadly superbugs in the lungs
12 déc. 2018 06h00 HE
|
Purdue Research Foundation
West Lafayette, Ind., Dec. 12, 2018 (GLOBE NEWSWIRE) -- Purdue University researchers have developed a new approach to treating the fourth-leading cause of death worldwide – lower respiratory...
InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones
08 nov. 2018 08h05 HE
|
InCarda Therapeutics, Inc.
Oversubscribed $42 Million Series B Financing Provides Significant Runway to Support Continued Advancement of Innovative Inhaled Cardiovascular Therapy First Patients Dosed in Phase 2 Clinical Trial...
BioNebicine Corp. Commences Tests of Nebulizer Device
04 sept. 2018 13h48 HE
|
BioNebicine Corp.
St. Petersburg, FL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioNebicine Corp. (“BioNebicine” or the “Company”) a privately held biotech company, is pleased to announce that it has...
MedInvent Receives CE Mark for NasoNeb II Nasal Nebulizer
14 mars 2017 09h05 HE
|
MedInvent
CLEVELAND, March 14, 2017 (GLOBE NEWSWIRE) -- MedInvent, LLC, is pleased to announce CE Marking of its patented intranasal delivery device, the NasoNeb II Nasal Nebulizer, manufactured, marketed and...